Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders
Robert Roskoski
Topics & Concepts
RuxolitinibJanus kinaseTyrosine kinase 2TofacitinibCancer researchCytokine receptorJanus kinase 2Polycythemia veraMyelofibrosisJanus kinase 1Tyrosine kinaseMedicineKinaseBiologyCytokineImmunologyInternal medicinePlatelet-derived growth factor receptorReceptorRheumatoid arthritisCell biologyBone marrowGrowth factorCytokine Signaling Pathways and InteractionsPharmacological Effects of Natural CompoundsMyeloproliferative Neoplasms: Diagnosis and Treatment